Zurcher Kantonalbank (Zurich Cantonalbank)

Bank

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1368163 ZURICH, V8

Position in INBX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$34,773

+$21,731 QoQ

Shares Held

367

+89.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#134

of 161 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Zurcher Kantonalbank (Zurich Cantonalbank) holds $584,419,908 across 174 Biotechnology names. INBX ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	380,762	$189,135,908
2	JAZZ	Jazz Pharmaceuticals plc	431,148	$103,893,733
3	REGN	Regeneron Pharmaceuticals, Inc.	63,644	$39,684,579
4	INCY	Incyte Corp	172,016	$19,499,733
5	RPRX	Royalty Pharma plc	312,891	$17,543,798
6	RVMD	Revolution Medicines, Inc.	74,284	$13,911,907
7	ALNY	Alnylam Pharmaceuticals, Inc.	45,536	$13,707,702
8	MRNA	Moderna, Inc.	162,175	$11,357,115

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,773	367	+89.2%	Shares	Sole	2026-08-12
2026-03-31	$13,042	194	-61.0%	Shares	Sole	2026-05-15
2025-12-31	$39,342	498	0.0%	Shares	Sole	2026-01-27
2025-09-30	$16,772	498	-32.4%	Shares	Sole	2025-11-14
2025-06-30	$10,516	737	-10.6%	Shares	Sole	2025-08-07
2025-03-31	$11,527	824	+598.3%	Shares	Sole	2025-05-07
2024-12-31	$1,817	118	0.0%	Shares	Sole	2025-02-07
2024-09-30	$1,847	118	0.0%	Shares	Sole	2024-11-14
2024-06-30	$1,672	118	—	Shares	Sole	2024-07-29
No filing history on record for this holder in this stock.